Purpose Quantification of post-interventional adverse events of outpatient SIRT leading to
hospitalization and quantification of radiation exposure. Materials and methods In this single …

Background Using data collected in the prospective observational study CIRSE Registry for
SIR-Spheres Therapy, the present study aimed at identifying predictors of adverse events …

Abstract Radioembolization using Yttrium90 (90Y) microspheres is widely used to treat
primary and metastatic liver tumors. The present work provides minimum practice guidelines …

Objective To review the technical feasibility of resin microsphere (SIR-Spheres®) yttrium-90
radioembolization prescribed using the medical internal radiation dose (MIRD) model …

PURPOSE: To report the incidence of liver function test (LFT) toxicities after
radioembolization with yttrium-90 (90Y) SIR-Spheres and review potential risk factors …

Background: Radioembolization, also known as transarterial radioembolization or selective
internal radiation therapy with yttrium-90 (90Y) resin microspheres, is an established …

The absorbed doses in the liver and adjacent viscera in Yttrium90 radioembolization
therapy for metastatic liver lesions are not welldocumented. We sought for a clinically …

Transarterial radioembolization using yttrium-90 (Y-90) microspheres is an important
therapy in the management of unresectable primary liver tumors or hepatic metastases …

The past decade has seen significant advancement in the locoregional management of liver
tumors; novel and promising therapies such as transarterial chemoembolization …

Selective internal radiation therapy (SIRT) with 90yttrium microspheres is a relatively new
clinical modality for treating nonresectable malignant liver tumours. This interventional …